Disease Info Card

Odontogenic Tumors

Information about Odontogenic Tumors: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Odontogenic Tumors

Most recent studies have shown that Odontogenic Tumors shares some biological mechanisms with adenomatoid-odontogenic-tumor, ameloblastic-fibroma, ameloblastoma, calcifying-epithelial-odontogenic-tumor, calcifying-odontogenic-cyst, calcinosis, carcinoma, cementoma, dentigerous-cyst, fibroma, impacted-tooth, jaw-neoplasms, malignant-paraganglionic-neoplasm, mandibular-neoplasms, maxillary-neoplasms, myxoma, neoplasm-recurrence-local, neoplasms, odontogenic-cysts, odontoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Odontogenic Tumors, and have been seen in publications frequently: Amelogenesis, Angiogenesis, Bone Resorption, Cell Adhesion, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Enucleation, Keratinization, Localization, Odontogenesis, Oncogenesis, Pathogenesis, Pigmentation, Regeneration, Secretion, Tooth Eruption

Quite a number of genes have been found to play important roles in Odontogenic Tumors, such as AMBN, BCL2, CKAP4, EGFR, KRT14, KRT19, MMP2, MMP9, ODAM, PCNA, PTCH1, RPE65, SHH, SS18L1, TNFRSF11B, TP53, TP63, UVRAG, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.